Need Help? Contact Us.

Enquire now


Product Description

The IDS Androstenedione assay is a fully automated chemiluminescence immunoassay (CLIA) for the quantitative determination of androstenedione in human serum on the IDS system. Results are to be used in conjunction with other clinical and laboratory data to assist clinicians in the diagnosis and monitoring of androgen disorders.

  • Excellent functional sensitivity and precision
  • No biotin interference
  • Extensive reference intervals by age and gender for adults and paediatrics
  • One tube for multiple hormone measurements
  • Rapid management of androgen disorders
    1. Devlin TM. Textbook of Biochemistry: with Clinical Correlations (7th ed.). Hoboken, NJ: John Wiley & Sons. 2010: p. 432
    2. Odell WD, Parker LN. Control of adrenal androgen production. Endocr Res. 1984-1985;10(3-4):617-30
    3. Lizneva D, Gavrilova-Jordan L, Walker W, Azziz R. Androgen excess: Investigations and management. Best Pract Res Clin Obstet Gynaecol. 2016 Nov;37:98-118
    4. Speiser PW and White PC. Congenital adrenal hyperplasia The New England Journal of Medicine, vol. 349,no. 8, pp. 776–788, 2003

Add to Enquiry Basket



Related Products

Assays Certification Platform Clinical Area Portfolio RUO/IVD
17-OH Progesterone CE MarkedFDA Cleared i10iSYS Endocrine Reproductive Endocrinology IVD
SHBG CE MarkedFDA Cleared i10iSYS Endocrine Reproductive Endocrinology IVD
Total Testosterone CE Marked i10iSYS Endocrine Reproductive Endocrinology IVD
This site is registered on as a development site.